Tradestie Institutional Equity Comparison Engine

XOMA vs AGEN โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

AGEN Overall Edge

AGEN Captures Institutional Edge (4โ€“0 Pillars ยท 3โ€“7 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Agenus Inc. (AGEN) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, XOMA trades at 21.5x Forward P/E with -3.9% operating margin (-22.6% YoY revenue) versus AGEN at 3.7x Forward P/E and 38.9% operating margin (+4.1% YoY). In options structure, XOMA sits in UNCLASSIFIED (100th %ile IV; Dealer Gamma Walls on Pro) against AGEN sits in BREAKDOWN (11th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner AGEN
XOMA 21.5x vs AGEN 3.7x Fwd P/E
Growth & Margin Winner AGEN
Op Margin -3.9% vs 38.9% ยท YoY -22.6% vs +4.1%
Momentum & Technical Winner AGEN
1Y +44.0% vs +46.4% ยท 52W Pos 78% vs 48%
Options & Structure Winner AGEN
UNCLASSIFIED (100th %ile IV) vs BREAKDOWN (11th %ile IV)
XOMA NASDAQ
XOMA Royalty Corporation Common Stock
Pharmaceutical Preparations
$40.17
-9.16% 1D
Market Cap $781.8M
1M Return -3.81%
1Y Return +43.98%
Forward P/E 21.5x
Unified AI Score
55.8 / 100 HOLD
Tech 40.0 Fund 52.0 Flow 50.0 Mom 64.0
AGEN NASDAQ
Agenus Inc.
Biological Products, (No Disgnostic Substances)
$6.34
-5.79% 1D
Market Cap $310.8M
1M Return +4.97%
1Y Return +46.42%
Forward P/E 3.7x
Unified AI Score
52.7 / 100 HOLD
Tech 44.0 Fund 55.0 Flow 66.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: XOMA +43.98% AGEN +46.42% Spread: +16.74 pp (AGEN Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
XOMA TTM Op. Margin: -3.9% AGEN TTM Op. Margin: 38.9%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on XOMA vs AGEN. Trailing 12-month operating profitability (XOMA -3.9% vs AGEN 38.9%) and valuation multiples (XOMA 21.5x vs AGEN 3.7x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: XOMA (7) vs AGEN (3)
Institutional Metric XOMA AGEN Criterion Row Winner
Market Capitalization Scale $781.8M $310.8M Larger Scale XOMA
Trailing P/E Ratio Valuation 28.2x 29.9x Lower Multiple XOMA
Forward P/E Ratio Valuation 21.5x 3.7x Lower Multiple AGEN
Revenue Growth (YoY) Growth -22.6% +4.1% Higher Growth AGEN
Operating Margin (TTM) Profitability -3.9% 38.9% Higher Margin AGEN
Net Profit Margin Profitability 69.6% 30.8% Higher Margin XOMA
Return on Equity (ROE) Capital Efficiency 34.2% -1278.8% Higher ROE XOMA
52-Week Range Position Momentum 78% ($22โ€“$45) 48% ($3โ€“$10) Stronger Trend XOMA
Beta / 30D Volatility Risk Regime 0.68ฮฒ ยท 37% Vol 1.60ฮฒ ยท 76% Vol Lower Realized Risk XOMA
Unified Institutional Score Composite Signal 55.8 / 100 (HOLD) 52.7 / 100 (HOLD) Higher Composite XOMA

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full XOMA vs AGEN Buy Guide
XOMA UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 100th %ile
IV Regime Extreme (>80th %ile)
Live XOMA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
AGEN BREAKDOWN
33d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 11th %ile
IV Regime Compressed (<25th %ile)
Live AGEN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither XOMA nor AGEN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.